IP Library Granted Patent US 10,993,876
Granted Patent B2
US 10,993,876 · App. 16/372,006 · Granted May 4, 2021

Pharmaceutical compounding methods and systems

Inventors: Panagiota Danopoulos (St-Laurent, CA); Marc Joiner (St-Laurent, CA); Sarah Nyat Peng Wong (St-Laurent, CA); Vargha Talebi (St-Laurent, CA)
Assignee: MEDISCA PHARMACEUTIQUE INC.
A61J1/05A61J3/04A61K9/0034A61K9/06A61K9/107A61K31/045A61K31/135A61K31/137A61K31/192A61K31/195A61K31/196A61K31/197A61K31/351A61K31/445A61K31/4418A61K31/4422A61K31/4458A61K31/565A61K31/57A61K31/7048A61K33/14A61K47/10A61K47/26A61K47/38A61K47/42A61K47/46B01F9/0001B01F9/0018B01F9/0032B01F9/0034B01F11/00B01F15/0074B01F15/00253B65B7/16B01F2009/0085
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,993,876
App. No.
16/372,006
Granted
May 4, 2021
Kind
B2
Abstract

The present disclosure relates to a system and process for manufacturing patient personalized pharmaceutical compositions using superimposed revolution and rotation movements for dispersing, milling, melting, and/or de-aerating, where these superimposed revolution and rotation movements can be carried out in a single device in a pharmacy setting.

Claims (32)

1. A compounding method, comprising:

a) placing in a container a suppository or troche containing a gelatin gum base; and

b) melting the suppository or troche containing the gelatin gum base by subjecting the container to superimposed revolution and rotation movements that are sufficient to melt the suppository or troche containing the gelatin gum base, to obtain a pourable liquid.

2. The compounding method of claim 1 , wherein the suppository or troche containing the gelatin gum base can be reversibly melted.

3. The compounding method of claim 1 , further comprising incorporating the pourable liquid into a mold having a predetermined shape and causing the pourable liquid to solidify into the mold shape to obtain a solid, semi-solid, or chewable composition.

4. The compounding method of claim 1 , wherein the superimposed revolution and rotation movements are performed for 20 seconds to 900 seconds.

5. The compounding method according to claim 1 , wherein the superimposed revolution and rotation movements induce a maximal G force from 50 g to 500 g.

6. The compounding method according to claim 1 , wherein the revolution and rotation movements have a revolution:rotation ratio of 10:4.

7. The compounding method according to claim 1 , wherein the container has a base diameter (B) and the suppository or troche base occupies a height (H) within the container such that there is a height-to-base ratio (HBR) within a range of 0.75:1 to 1.5:1.

8. The compounding method according to claim 1 , wherein subjecting the container to said superimposed revolution and rotation movements includes subjecting the container to first superimposed revolution and rotation movements sufficient to melt the suppository or troche base and subsequently subjecting the container to second superimposed revolution and rotation movements.

9. The compounding method according to claim 8 , wherein the container includes the melted suppository or troche base with an active pharmaceutical ingredient (API) during the second superimposed revolution and rotation movements.

10. The compounding method according to claim 8 , wherein the container includes the melted suppository or troche base without an active pharmaceutical ingredient (API) during the first superimposed revolution and rotation movements.

11. The compounding method according to claim 8 , further comprising adding an active pharmaceutical ingredient (API) to the melted suppository or troche base after the first superimposed revolution and rotation movements and before the second superimposed revolution and rotation movements.

12. The compounding method of claim 1 , wherein, in subjecting the container to the superimposed revolution and rotation movements, the revolution speed and a time for subjecting the container to the superimposed revolution and rotation movements are selected so as to melt the mass of the suppository or troche base into the pourable liquid.

13. A compounding method for melting a troche or suppository base, comprising:

placing in a container pieces of the troche or suppository base, the suppository or troche base containing a gelatin gum base; and

melting the troche or suppository base by subjecting the container to superimposed revolution and rotation movements to cause an elevation in temperature of the troche or the suppository base sufficient for melting the pieces into a pourable liquid.

14. The compounding method according to claim 13 , wherein the superimposed revolution and rotation movements are performed for at least 20 seconds.

15. The compounding method according to claim 14 , wherein the superimposed revolution and rotation movements are performed for up to 900 seconds.

16. The compounding method according to claim 13 , wherein the maximal G force is of at least 50 g.

17. The compounding method according to claim 16 , wherein the maximal G force is up to 500 g.

18. The compounding method according to claim 13 , wherein the movements have a revolution:rotation ratio of 10:4.

19. The compounding method according to claim 13 , wherein the movements have a revolution speed of at least 400 revolution per minute (rpm).

20. The compounding method according to claim 13 , wherein the revolution speed is in the range of from 400 to 4000 rpm.

21. The compounding method according to claim 13 , wherein the subjecting of the container to the superimposed revolution and rotation movements includes subjecting the container to first superimposed revolution and rotation movements sufficient to melt the pieces of the troche or suppository base into the pourable liquid and subsequently subjecting the container to second superimposed revolution and rotation movements for mixing the pourable liquid.

22. The compounding method of claim 21 , wherein, during the second superimposed revolution and rotation movements, the pourable liquid comprises an active pharmaceutical ingredient (API).

23. The compounding method of claim 21 , wherein, during the first superimposed revolution and rotation movements, the container includes the pourable liquid without an active pharmaceutical ingredient (API).

24. The compounding method according to claim 23 , further comprising incorporating the API into the liquid after the first superimposed revolution and rotation movements and before the second superimposed revolution and rotation movements.

25. The compounding method of claim 13 , wherein, in subjecting the container to the superimposed revolution and rotation movements, the revolution speed and a time for subjecting the container to the superimposed revolution and rotation movements are selected so as to melt the mass of the suppository or troche base into the pourable liquid.

26. A compounding method, comprising:

placing in a container a suppository or troche base containing a gelatin gum base; and

melting the suppository or troche base by subjecting the container to superimposed revolution and rotation movements sufficient to cause a change in temperature in the suppository or troche base of between about 27 and 50 degrees Celsius to obtain a pourable liquid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2019
From: MEDISCA INC.
To: MEDISCA PHARMACEUTIQUE INC.
Reel/Frame 048912/0321 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: DANOPOULOS, PANAGIOTA; NYAT PENG WONG, SARAH; TALEBI, VARGHA
To: MEDISCA PHARMACEUTIQUE INC.
Reel/Frame 048895/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 16, 2019
From: JOINER, MARC
To: MEDISCA INC.
Reel/Frame 048895/0169 →
Continuity (4)
Continuation 16131986 · Sep 14, 2018
Continuation 15809636 · Nov 10, 2017
Provisional Application 62420426 · Nov 10, 2016
Related Publication 20190224073A1 · Jul 25, 2019
Cited By (4)
US 12,213,941 US 12,295,909 US 12,396,924 US 12,403,069